KDR and cancer: In continuation of our previous work on synthesizing new, potent, and safe anticancer agents [12,27,28,29,30,31,32], new nicotinamide derivatives were synthesized that keep the essential pharmacophoric features of VEGFR-2 inhibitors, aiming for the development of efficient anticancer agents that target VEGFR-2 inhuman cancer cell lines.